cas 136866-27-8|| where to buy 3,5-Dichloropyrazine-2-carbaldehyde

Nom du produit:3,5-Dichloropyrazine-2-carbaldehyde

IUPAC Name:3,5-dichloropyrazine-2-carbaldehyde

Unité d'emballage	Stock disponible	Prix($)
CM106723-100mg	in stock	ȖŪƃ
CM106723-250mg	in stock	Ūȅȅ
CM106723-1g	in stock	Şƃȅ
CM106723-5g	in stock	ȖŞŪŞ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Notes supplémentaires

Verification code*

refresh

: N° CAS:136866-27-8; Formule moléculaire:C5H2Cl2N2O; Point de fusion:-; Code SMILES:ClC1=NC(Cl)=C(C=O)N=C1; Densité:

: Numéro de catalogue:CM106723; Poids moléculaire:176.98; Point d'ébullition:240.8°C at 760 mmHg; N° Mdl:MFCD09864908; Stockage:Keep in inert atmosphere, store at 2-8°C.

: Pyrazines; Pyrazine is a heterocyclic aromatic organic compound with chemical formula C4H4N2. The marketed pyrazine drugs are mainly distributed in the field of anti-tumor and anti-infection. In recent years, there have been many new drugs in various fields, and there are some new target drugs worthy of attention.; pyrazine,pyrazine price; if you want to know the latest news about pyrazine and pyrazine price, please come to our website and get a quote for free.

: GDC-1971; Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.